Bliss Gvs Pharma Limited (BLISSGVS)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
71.75
-1.3(-1.78%)

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, the company offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, anti-flatulent, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, acne, emollient, anti- glaucoma, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, b-complex, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, mouth ulcer, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and multivitamin and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. It also exports its products. The company was incorporated in 1984 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

72.4

TODAY'S LOW

68.2

52 WEEK HIGH

128.45

52 WEEK LOW

66.1

Major Holders

% of Shares Held by
All Insider

63.02%

% of Shares Held by
Institutions

9.87%

% of Float Held by
Institutions

26.70%

Number of Institutions
Holding Shares

5

Company Overview

MARKET CAP

745 Cr.

ETERPRISE VALUE

835.72 Cr.

NO. OF SHARES

10.37 Cr.

BOOK VALUE

82.296

DIV. YIELD

0.5%

DEBT

0

GROSS PROFIT

240.46 Cr.

CASH

0

REVENUE

712.44 Cr.

REVENUE/SHARE

68.509

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments-43.68 Cr.2.36 Cr.-39.68 Cr.54.20 Cr.
Change To Liabilities-14.67 Cr.12.84 Cr.20.51 Cr.-39.81 Cr.
Total cashflows from Investing Activities-46.99 Cr.-47.89 Cr.-73.51 Cr.50.23 Cr.
Net Borrowings-8.92 Cr.11.07 Cr.22.68 Cr.-19.66 Cr.
Total Cash from Financing Activities-20.79 Cr.-6.30 Cr.16.83 Cr.-75.97 Cr.
Other Liabilities-79.33 Cr.-5.43 Cr.-3.08 Cr.-54.58 Cr.
Total Assets0000
Net Income68.49 Cr.97.26 Cr.123.72 Cr.58.78 Cr.
Change in Cash-2.20 Cr.30.30 Lakhs-21.91 Cr.-10.46 Cr.
Effect of Exchange Rate1.61 Cr.7.74 Cr.-5.17 Cr.-2.36 Cr.
Total Cash from Operating Activities63.96 Cr.46.70 Cr.39.95 Cr.17.63 Cr.
Depreciation17.02 Cr.12.36 Cr.8.70 Cr.21.38 Cr.
Other Cashflows from Investing Activities5.38 Cr.8.09 Cr.3.72 Cr.11.40 Cr.
Dividends Paid-5.54 Cr.-12.50 Cr.-8.23 Cr.-7.44 Cr.
Change to Inventory-26.80 Cr.80.55 Lakhs-18.33 Cr.-9.33 Cr.
Change to Account Receivables62.92 Cr.-78.53 Cr.-182.16 Cr.-37.06 Cr.
Other Cashflows from Financing Activities-6.31 Cr.-4.88 Cr.2.38 Cr.-48.86 Cr.
Change to Net Income36.13 Cr.7.16 Cr.90.35 Cr.78.26 Cr.
Capital Expenditures-9.12 Cr.-59.25 Cr.-43.76 Cr.-28.21 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax104.12 Cr.128.96 Cr.181.91 Cr.63.99 Cr.
Minority Interest19.65 Cr.14.75 Cr.13.86 Cr.11.47 Cr.
Net Income89.44 Cr.111.14 Cr.151.06 Cr.87.13 Cr.
Selling General Administrative81.16 Cr.67.07 Cr.66.01 Cr.43.21 Cr.
Gross Profit240.46 Cr.242.26 Cr.281.36 Cr.173.57 Cr.
Ebit89.44 Cr.111.14 Cr.151.06 Cr.87.13 Cr.
Operating Income89.44 Cr.111.14 Cr.151.06 Cr.87.13 Cr.
Other Operating Expenses51.07 Cr.50.17 Cr.46.57 Cr.34.15 Cr.
Interest Expense-4.30 Cr.-6.89 Cr.-4.13 Cr.-8.19 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense30.15 Cr.33.71 Cr.55.25 Cr.32.26 Cr.
Total Revenue577.20 Cr.689.30 Cr.898.57 Cr.372.01 Cr.
Total Operating Expenses487.75 Cr.578.16 Cr.747.50 Cr.284.88 Cr.
Cost of Revenue336.73 Cr.447.04 Cr.617.20 Cr.198.44 Cr.
Total Other Income Expense Net14.67 Cr.17.81 Cr.30.84 Cr.-23.13 Cr.
Discontinued Operations00029.03 Cr.
Net Income from Continuous Ops.73.97 Cr.95.25 Cr.126.66 Cr.31.72 Cr.
Net Income Applicable to Common Shares68.49 Cr.97.26 Cr.123.72 Cr.58.78 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets57.85 Lakhs64.23 Lakhs52.68 Lakhs51.78 Lakhs
Capital Surplus14.75 Cr.14.75 Cr.14.75 Cr.14.75 Cr.
Total Liabilities248.87 Cr.276.84 Cr.245.01 Cr.312.31 Cr.
Stock Holder Equity808.25 Cr.735.61 Cr.645.99 Cr.536.23 Cr.
Minority Interest19.65 Cr.14.75 Cr.13.86 Cr.11.47 Cr.
Other Liabilities38.51 Cr.51.65 Cr.55.70 Cr.126.91 Cr.
Total Assets1076.78 Cr.1027.22 Cr.904.87 Cr.860.03 Cr.
Common Stock10.31 Cr.10.31 Cr.10.31 Cr.10.31 Cr.
Retained Earnings782.64 Cr.718.78 Cr.633.18 Cr.522.05 Cr.
Other Liabilities10.80 Cr.6.10 Cr.5.45 Cr.7 Cr.
Good Will7.71 Cr.7.71 Cr.9.64 Cr.9.64 Cr.
Treasury Stock53.76 Lakhs-8.24 Cr.-12.25 Cr.-10.88 Cr.
Other Assets13.46 Cr.15.48 Cr.19.64 Cr.33.27 Cr.
Cash12.63 Cr.15.08 Cr.15.03 Cr.36.94 Cr.
Current Liabilities203.63 Cr.230.52 Cr.207.02 Cr.299.39 Cr.
Long Term Asset Charges0000
Short Long Term Debt21.11 Cr.17.33 Cr.5.10 Cr.6.38 Cr.
Other Stockholder Equity53.76 Lakhs-8.24 Cr.-12.25 Cr.-10.88 Cr.
Property Plant Equipment227.82 Cr.232.61 Cr.181.53 Cr.126.77 Cr.
Total Cur. Assets765.19 Cr.769.73 Cr.693.49 Cr.689.78 Cr.
Long Term Investments62.01 Cr.1.02 Cr.2.94 Lakhs2.46 Lakhs
Net Tangible Assets799.96 Cr.727.25 Cr.635.82 Cr.526.07 Cr.
Short Term Investments49.02 Cr.24.62 Cr.71.82 Cr.17.46 Cr.
Net Receivables499.11 Cr.573.23 Cr.495.30 Cr.414.24 Cr.
Long Term Debt32.60 Cr.37.23 Cr.32.53 Cr.5.91 Cr.
Inventory98.92 Cr.74.13 Cr.77.36 Cr.59.03 Cr.
Accounts Payable74.22 Cr.89.91 Cr.78.88 Cr.58.43 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account